{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"TrueLife","title":"Anthony Bailey & Dr. Mitsis - Entheogen Biotech","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/59d78be4\"></iframe>","width":"100%","height":180,"duration":7463,"description":"https://www.entheogenbiotech.ca/\r\n\r\nArticle: https://sflcn.com/entheogen-biotech-of-canada-conducting-research-on-mushrooms-in-jamaica/  \r\nBioreactor: https://youtu.be/gIUHQNFKu_I\r\nqNMR http\r\n\r\nToday we welcome Anthony Bailey and Co- Founder of Entheogen Biotech to the TrueLife podcast. \r\n\r\nThey have established a library with strains as strong as 4.4% tryptamine content.\r\n\r\n In establishing our library of over 100 strains of fungi we've established analytic techniques to determine tryptamine contents at home for up to 2% tryptamine and new methods using each HPLC's and Q NMR's machines. \r\n\r\nOur most unique offering is strain of mycelium that we stumbled upon in our breeding process, this particular strain produces psilocybin. We then took this strain and grew it in a bioreactor producing psilocybin in one-week versus the traditional eight-week life cycle of psilocybin.\r\n\r\nNow we embark on commercialising our findings and bring them to market their legal jurisdiction permits.","thumbnail_url":"https://img.transistorcdn.com/FV-M9IcfmmK0PpSjnssPkhI7AX9NSl6NdRLN8MmGBl8/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzExODc0LzE2NzI1/NDI0ODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}